Delivery Order SPE2DB22D9244-SPE2DB25FZS60
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,315.80 to DMS Pharmaceutical Group Inc. for MITOSOL 0.2 mg kits, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. will deliver the pharmaceutical product to its place of performance location in Park Ridge, IL. This delivery...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of MITOSOL 0.2 MG KITS. The contract, which has a potential value of $7,894.80, has a completion date of March 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of brand and generic prescription and over-the-counter drug supplies to government...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $1,315.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Mitosol 0.2mg kits, a pharmaceutical product, with a period of performance through April 4, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract 4600082013 with the DLA, valued at up...
- The Defense Logistics Agency awarded a $3,947.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, utilizes a firm fixed-price structure and carries no set-aside designation. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $23,684.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract is firm fixed-price with an ultimate completion date of August 25, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive position as a small business in federal procurement markets. Performance will be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,263.24 by the Defense Logistics Agency on August 20, 2025, for the supply of Mitosol 0.2 mg kits. The delivery order carries an ultimate completion date of September 11, 2025, and no set-aside designation was used in the procurement. This award represents a continuation of the company's established role as a critical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,315.80 by the Medical Supply Chain division of the Defense Logistics Agency on July 25, 2025. The delivery order, which is expected to be completed by August 14, 2025, covers the supply of Mitosol 0.2mg kits in quantities of three units. This award was issued without a set-aside designation, and the place of performance is...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,684.40, is for the delivery of MITOSOL 0.2MG KITS 3S and has a period of performance through June 28, 2024. This order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide MITOSOL 0.2 MG KITS. The order, valued at $5,263.24, has a completion date of January 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products in support of military treatment facilities worldwide. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,526.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through November 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program to provide a broad range of...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB25FZS60Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,263.24 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler, which is based in Park Ridge, Illinois and will perform the work at that same location. DMS Pharmaceutical Group Inc. operates under a larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities. As a long-standing federal contractor registered in the System for Award Management since 2001, the company has demonstrated consistent capability in supplying prescription medications, biologics, and medical consumables to military health installations nationwide, positioning it as a key supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/21/25 |